| Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene G Cartron, L Dacheux, G Salles, P Solal-Celigny, P Bardos, P Colombat, ... Blood, The Journal of the American Society of Hematology 99 (3), 754-758, 2002 | 2426 | 2002 |
| Follicular lymphoma international prognostic index P Solal-Céligny, P Roy, P Colombat, J White, JO Armitage, R Arranz-Saez, ... Blood 104 (5), 1258-1265, 2004 | 2131 | 2004 |
| High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma T Philip, JO Armitage, G Spitzer, F Chauvin, S Jagannath, JY Cahn, ... New England Journal of Medicine 316 (24), 1493-1498, 1987 | 913 | 1987 |
| Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden: clinical and molecular evaluation P Colombat, G Salles, N Brousse, P Eftekhari, P Soubeyran, V Delwail, ... Blood, The Journal of the American Society of Hematology 97 (1), 101-106, 2001 | 725 | 2001 |
| Rituximab-dependent cytotoxicity by natural killer cells: influence of FCGR3A polymorphism on the concentration-effect relationship S Dall’Ozzo, S Tartas, G Paintaud, G Cartron, P Colombat, P Bardos, ... Cancer research 64 (13), 4664-4669, 2004 | 542 | 2004 |
| Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support N Milpied, E Deconinck, F Gaillard, V Delwail, C Foussard, C Berthou, ... New England Journal of Medicine 350 (13), 1287-1295, 2004 | 486 | 2004 |
| Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study C Charlier, É Perrodeau, A Leclercq, B Cazenave, B Pilmis, B Henry, ... The Lancet Infectious Diseases 17 (5), 510-519, 2017 | 483 | 2017 |
| A uniform activated B-cell–like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 cases S Camilleri-Broët, E Criniere, P Broët, V Delwail, K Mokhtari, A Moreau, ... Blood 107 (1), 190-196, 2006 | 430 | 2006 |
| The impact of organizational factors on psychological needs and their relations with well-being N Gillet, E Fouquereau, J Forest, P Brunault, P Colombat Journal of Business and Psychology 27, 437-450, 2012 | 374 | 2012 |
| High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial D Rossille, M Gressier, D Damotte, D Maucort-Boulch, C Pangault, ... Leukemia 28 (12), 2367-2375, 2014 | 353 | 2014 |
| The mediating role of organizational justice in the relationship between transformational leadership and nurses’ quality of work life: A cross-sectional questionnaire survey N Gillet, E Fouquereau, A Bonnaud-Antignac, R Mokounkolo, P Colombat International journal of nursing studies 50 (10), 1359-1367, 2013 | 298 | 2013 |
| Procedural justice, supervisor autonomy support, work satisfaction, organizational identification and job performance: The mediating role of need satisfaction and perceived … N Gillet, P Colombat, E Michinov, AM Pronost, E Fouquereau Journal of advanced nursing 69 (11), 2560-2571, 2013 | 289 | 2013 |
| Perceived organizational support, motivation, and engagement among police officers. N Gillet, I Huart, P Colombat, E Fouquereau Professional Psychology: Research and Practice 44 (1), 46, 2013 | 281 | 2013 |
| High-dose therapy followed by autologous purged stem-cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized … E Deconinck, C Foussard, N Milpied, P Bertrand, P Michenet, ... Blood 105 (10), 3817-3823, 2005 | 265 | 2005 |
| Induction of monocyte tissue factor expression by antibodies to heparin–platelet factor 4 complexes developed in heparin-induced thrombocytopenia C Pouplard, S Iochmann, B Renard, O Herault, P Colombat, J Amiral, ... Blood, The Journal of the American Society of Hematology 97 (10), 3300-3302, 2001 | 233 | 2001 |
| High-dose therapy followed by autologous purged stem cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized … E Gyan, C Foussard, P Bertrand, P Michenet, S Le Gouill, C Berthou, ... Blood, The Journal of the American Society of Hematology 113 (5), 995-1001, 2009 | 209 | 2009 |
| Prognostic factors for survival after high-dose therapy and autologous stem cell transplantation for patients with relapsing Hodgkin’s disease: analysis of 280 patients from … P Brice, R Bouabdallah, P Moreau, M Divine, M Andre, M Aoudjane, ... Bone marrow transplantation 20 (1), 21-26, 1997 | 204 | 1997 |
| Impact of [(18) F] fluorodeoxyglucose positron emission tomography response evaluation in patients with high-tumor burden follicular lymphoma treated with immunochemotherapy: a … J Dupuis, A Berriolo-Riedinger, A Julian, P Brice, C Tychyj-Pinel, H Tilly, ... J Clin Oncol 30 (35), 4317-4322, 2012 | 203 | 2012 |
| Upfront VIP‐reinforced‐ABVD (VIP‐rABVD) is not superior to CHOP/21 in newly diagnosed peripheral T cell lymphoma. Results of the randomized phase III trial GOELAMS‐LTP95 A Simon, M Peoch, P Casassus, E Deconinck, P Colombat, B Desablens, ... British journal of haematology 151 (2), 159-166, 2010 | 196 | 2010 |
| Comparison of high-dose therapy and autologous stem-cell transplantation with conventional therapy for Hodgkin's disease induction failure: a case-control study M André, M Henry-Amar, JL Pico, P Brice, D Blaise, M Kuentz, B Coiffier, ... Journal of clinical oncology 17 (1), 222-222, 1999 | 195 | 1999 |
